Invitation to Make a Positive ImpactEstablished in 1996, the Prostate Cancer Research Institute was founded to provide current, unbiased information to men who face the intimi-dating prospect of choosing their own treatment.
PCRI believes that patients empowered with understandable education-al and medical information will ultimately benefit with better cure rates and an improved quality of life.
We invite you to participate in this year’s Prostate Cancer Conference in Los Angeles, California on September 7-9, 2012.
This is the thirteenth year PCRI is hosting this prestigious event. An impressive lineup of world-renowned prostate cancer experts will be presenting current information and cutting-edge research related to treatment and lifestyle issues.
This three-day event is expected to attract more than 800 prostate can-cer survivors, physicians, patient advocates, researchers and health-care professionals from around the world. The conference proceedings will be videotaped and distributed glob-ally to approximately 700 support groups, reaching thousands of prostate cancer survivors. The PCRI conference is a unique opportunity to reach a diverse group of stakeholders in the prostate cancer community.
Please review the accompanying Sponsoring & Exhibiting Opportunities and determine your level of invovle-ment and participation. If you need additional information or have any questions, please call 310.743.2116 or e-mail [email protected].
We look forward to seeing you in Los Angeles this September!
Sincerely,
Mark Scholz, MDExecutive Director
Prostate Cancer Research Institute 2012 CONFERENCE INVITATION - 2
Mark Scholz, MDPCRI Executive Director
About PCRI
MissionThe Prostate Cancer Research Institute is a 501 (c)(3) charitable not-for-profit organization whose mission is to improve the quality of men’s lives by supporting research and disseminat-ing information that educates and empowers patients, families and the medical community.
PCRI’s main objective is to educate patients, their families and physicians about prostate cancer by providing the most current information on prostate cancer diagnosis, staging, treatments and available resources.
PCRI believes that a patient who understands his disease and treatment options will be em-powered to communicate more effectively with his physician(s), and will obtain a better out-come. PCRI uses all available communication tools and programs, including a helpline, a quarterly and a weekly newsletter, website and professional conferences to accomplish this important educational objective.
BackgroundPCRI was founded in 1996 by Mark C. Scholz, MD and Stephen B. Strum, MD; two interna-tionally recognized medical oncologists specializing in prostate cancer, with support from the Daniel Freeman Hospital Foundation in Southern California.
Dr. Scholz and Dr. Strum’s vision was that an organization providing insightful clinical re-search, in conjunction with educational activities directed at both the patient and physician, would greatly enhance outcomes for prostate cancer patients everywhere.
Working after hours to contribute their professional skills to cutting-edge work on prostate cancer, Scholz and Strum made the results of their own clinical research and the work of other researchers available to patients and physicians. As a result, PCRI has been involved in impor-tant developments in prostate cancer therapy, discoveries that have a direct effect on the quality of life for men with prostate cancer.
2012 CONFERENCE INVITATION - 3Prostate Cancer Research Institute
PCRI Support LinePrograms
Prostate cancer comes in many forms and complex variations. Newly diagnosed men and their families are al-most always in a state of shock following their diagnosis, which can often impair the ability to think clearly and formulate a course of action.
Our support line staff facilitators receive up to fifty inquiries a day about prostate cancer. Calls and e-mails come in from all over the world, and come from patients, family members, friends, and even physicians. Our knowledgeable staff facilitators, based out of Los Angeles, California and Sanibel, Florida, work to provide cus-tomized medical information relevant to each individual’s needs.
Our goal is to connect the caller with state-of-the-art resources that raise the effectiveness of dialogue between the patient and his physician, while refraining from giving actual medical advice. The valuable service the sup-port line provides is magnified because technology is advancing rapidly, and what constitutes the best treatment is constantly evolving. Only well-trained, fully-involved staff facilitators can stay abreast of all these new devel-opments. The PCRI is happy to provide this service free of charge via both phone and e-mail.
NewslettersPCRI Insights
PCRI publishes a quarterly newsletter called Insights, which has a circulation of over 20,000 all over the world.
Its goal is to educate, inform and empower the prostate cancer community with the latest advances in prostate cancer treatment and prevention. Our target audience covers the wide range of sophisticated patients, research-ers, primary care physicians, urologists, radiation therapists and medical oncologists.
PCRI provides cutting-edge information about the most advanced thinking on prostate cancer management and men’s health. Anyone is welcome to receive a free subscription to Insights via regular mail, e-mail or both; and all back issues are available for download in PDF format on the PCRI website.
In December 2011, PCRI launched a brand-new weekly e-newsletter, PCRI Weekly, to complement the quarterly Insights newsletter and provide our readers with more frequent updates. PCRI Weekly is posted to the PCRI website every Thursday, and contains up-to-date, detailed information about the latest developments in prostate cancer treatment.
Every week, PCRI selects an abstract from an important study relevant to prostate cancer research and sum-marizes the results, with an easy-to-understand “takeaway message” for men with prostate cancer. Although the focus of this newsletter is on medical news, PCRI will publish occasional feature and human interest stories as well. Back issues of PCRI Weekly are available on the PCRI website.
NEW! PCRI Weekly
2012 CONFERENCE INVITATION - 4Prostate Cancer Research Institute
ProgramsAdvocacyWhile advocacy is not PCRI’s primary goal, the organization has attained a respected and credible voice in the medical, political and public arena. PCRI has judiciously come out in support of worthy prostate cancer-related causes to encourage increased research and to expedite FDA approval of new therapies.
In its efforts to speak and advocate on behalf of patients everywhere, PCRI and its staff have been cited in several news stories published by the following media organizations: •ABCWorldNewsTonight •NBC-TV •TheLosAngelesTimes •TheNewYorkTimes •TheWallStreetJournal •TheWashingtonPost •TVNZ:TheNewsofNewZealand
ResearchThe allocation of research dollars is managed by a distinguished board of physicians representing all the major disciplines involved in prostate cancer care. All serve as volunteers without any financial compensation from the PCRI.
Board Member Specialty AffiliationDuke Bahn, MD Radiology Prostate Institute of AmericaStanley Brosman, MD Urology Professor of Urology, UCLAArthur Lurvey, MD Endocrinology Chief Medical Officer, MedicareMark Scholz, MD Medical Oncology Executive Director, PCRIMichael Steinberg, MD Radiation Therapy Department Chief, UCLA
In addition to their extensive research experience, all of these doctors participate in the day-to-day care of men with prostate cancer, which provides a practical clinical perspective for evaluating the value of research propos-als.
In 2011, PCRI supported new, potentially breakthrough work at the following institutions: •MayoClinic:Researchintonewmethodstoinduceapatient’simmunesystemtoattackcancer. •UniversityofNijmegen,theNetherlands:ResearchtoimproveMRIimagingtodetectearly cancer spread. •UniversityofToronto:ResearchintoActiveSurveillanceformenwithearlystagedisease. •JohnWayneCancerInstitute:Researchprogramstoidentifyeffective,lessinvasivewaysto screen, diagnose and treat brain tumors, melanoma, and breast cancer. •ProstateCancerFoundation:Researchintobettertreatmentsforprostatecancer.
2012 CONFERENCE INVITATION - 5Prostate Cancer Research Institute
ProgramsPCRI ConferencesEvery September (prostate cancer awareness month), PCRI conferences bring hundreds of patients, caregivers, physicians and institutional supporters together for a weekend of interactive sessions and lectures. The 2011 PCRI conference drew more than 700 attendees from 41 states and nine countries.
Delivered by leading physicians, academics and scientists, the presentations are recorded on video and distribut-ed to hundreds of support group meetings around the world. Made possible by generous individual and corpo-rate supporters and a legion of dedicated volunteers, this annual conference brings people together who have an interest in topics related to prostate cancer.
In addition to hearing from experts with a wealth of knowledge about prostate cancer, the conference also allows attendees the benefit of connecting with fellow patients and others in the prostate cancer community. Attendees have the opportunity to attend the following sessions throughout the weekend:•Roundtablediscussion:Apanelofconferencefacultydiscusstheirmedicalopinionsonrealclinical cases. •Q&AwiththeSpeakers:Conferenceattendeesmayaskfacultyspecificquestionsinamoreintimate setting. •AsktheExperts:90-minuteinteractivesessionsthatfocusontopicssuchasMedicalOncology,Urol- ogy, Radiation Oncology, Immunotherapy, nutrition and a prostate-friendly lifestyle. •SupportGroups:WiththehelpofPCRI’spartnersandprofessionalfacilitators,supportgroupmeet- ings are offered to patients and their significant others.
2012 CONFERENCE INVITATION - 6Prostate Cancer Research Institute
NEW! PCRI Mentoring Program (coming this spring)In our continued effort to provide men with unbiased, scientifically accurate information about prostate cancer treatment options, PCRI is in the process of creating an educational program - a comprehensive training and mentoring course - to equip support group leaders across the country with the knowledge needed in a variety of topics to be effective and supportive leaders.
The online course will consist of a series of webinars by well-known medical professionals who are highly re-garded in their respective fields of prostate cancer research. The course will cover a wide range of topics, includ-ing (but not limited to) active surveillance, screening and prevention, imaging, and a detailed overview of the five “shades” of prostate cancer. It will be set up in the format of a regular online class, with required reading, lectures, homework and 2-3 exams.
The curriculum for the PCRI mentoring program is currently in the works, and we plan to launch in the spring of 2012.
NEW! PCRI Blue CommunityIn September 2011, PCRI launched a new website called the Blue Community, for men with prostate cancer and their families to network and share their experiences with others in their same risk category, or “shade” of blue (the awareness color for prostate cancer).
The PCRI Blue Community introduces the concept of different shades of blue as a way to navigate the various types of prostate cancer, and provides online discussion forums as a way for men to connect with one another. The Blue Community is rapidly growing, with over 400 active users taking advantage of the site.
WebsiteIn 1998, PCRI adopted the internet as an educational tool. Our website, PCRI.org, contains more than 5,000 pages of information, and currently averages more than 75,000 visitors and 900,000 page views per month.
PCRI.org contains a wealth of content, including medical articles by leading prostate cancer specialists, risk evaluation tools, information about clinical trials, support groups, past issues of our newsletters, patient assis-tance programs, videos and more.
The website provides an introduction to assist a newly diagnosed patient in understanding the biology and extent of his prostate cancer. This understanding is the first step to empowerment that leads to determining his choice of if, when and how to treat his disease.
Programs
ManagementPCRI undergoes an annual financial audit, and consistently receives a “Best in America” seal of approval from the Independent Charities of America.
The Independent Charities Seal of Excellence is awarded after rigorous indepen-dent review. Only charities meeting the highest standards of public accountability, program effectiveness, and cost effectiveness are eligible. These standards include those required by the U.S. government for inclusion in the Combined Federal Campaign, possibly the most exclusive fund drive in the world.
Of the 1 million charities operating in the United States today, it is estimated that fewer than 50,000 – or 5 percent – meet or exceed these standards, and, of those, fewer than 2,000 have been awarded the Seal.
2012 CONFERENCE INVITATION - 7Prostate Cancer Research Institute
Chester A. Swenson, PresidentJeromeSeliger,PhD,Vice PresidentBarryL.Friedman,JD,SecretaryT.KentGraham,TreasurerDukeK.Bahn,MDStanley A. Brosman, MD
Mark Scholz, MD, Executive DirectorCathy Williams, Chief Operating OfficerTomGallatin,General Manager/GrantsLaurie Sorrow, Programs Coordinator
PCRI Staff
Scott CohenArthur N. Lurvey, MDJerryPetersClaudia B. Sangster, Esq.Mark C. Scholz, MD, PCRI Co-founderMichael Steinberg, MD, FAC
Madhu Rajaraman, Senior Writer/EditorJanManarite,Senior Educational FacilitatorNathan Roundy, Educational FacilitatorSilvia Cooper, Educational Facilitator
Contact Information
Prostate Cancer Research Institute5777 W. Century Blvd., Suite 800Los Angeles, CA 90045
(800) 641-PCRI (7274)Administrative (310) 743-2116Fax (310) 743-2113Helpline (310) 743-2110
E-mail: [email protected]: www.pcri.orgBlue Community: www.pcribc.org
2012 CONFERENCE INVITATION - 8Prostate Cancer Research Institute
Board of DirectorsPCRI Board & Staff
Sponsoring & Exhibiting OpportunitiesUNDERWRITING SPONSORMINIMUM CONTRIBUTION OF $50,000• Organization name and logo printed on: Banner at conference site Conference brochure Back cover of official program book Conference tote bags ConferenceDVDs Step and Repeat PCRI website, with link posted through September 30, 2012• Event hosting (promotional reception, breakfast, lunch, etc.)• Complimentary hospitality room• Acknowledgement on conference advertising• Organization information inserted in conference tote bags• 6’ x 40’ display/exhibit area• Organizational write-up in PCRI Insights newsletter (February, May, August or November issue)• Namedlecture-TBD• Registration and badges for up to 20 people• 20 tickets to Saturday night event• 20 tickets to Friday night reception• Acknowledgement during Saturday night event and Friday night reception
PLATINUM SPONSORMINIMUM CONTRIBUTION OF $30,000• Organization name and logo printed on: Conference brochure Inside back/front cover of official program book ConferenceDVDs Step and Repeat PCRI website, with link posted through September 30, 2012• Event hosting (promotional reception, breakfast, lunch, etc.)• Acknowledgement on conference advertising• Organization information inserted in conference tote bags• 6’ x 20’ display/exhibit area• Organizational write-up in PCRI Insights newsletter (February, May, August or November issue)• Namedlecture-TBD• Registration and badges for up to 15 people• 15 tickets to Saturday night event• 15 tickets to Friday night reception• Acknowledgement during Saturday night event and Friday night reception
Prostate Cancer Research Institute Sponsoring & Exhibiting Opportunities - 1
Sponsoring & Exhibiting OpportunitiesGOLD SPONSORMINIMUM CONTRIBUTION OF $20,000• Organization name and logo printed on: Conference brochure Goldpageofofficialprogrambook ConferenceDVDs PCRI website, with link posted through September 30, 2012• Acknowledgement on conference advertising• Organization information inserted in conference tote bags• 6’ x 15’ display/exhibit area• Organizational write-up in PCRI Insights newsletter (February, May, August or November issue)• Registration and badges for up to 10 people• 10 tickets to Saturday night event• 10 tickets to Friday night reception
SILVER SPONSORMINIMUM CONTRIBUTION OF $10,000• Organization name and logo printed on: Conference brochure Silver page of official program book ConferenceDVDs PCRI website, with link posted through September 30, 2012• Acknowledgement on conference advertising• Organization information inserted in conference tote bags• 6’ x 10’ display/exhibit area• Registration and badges for up to 5 people• 5 tickets to Friday night reception
EXHIBITORMINIMUM CONTRIBUTION OF $5,000• Organization name and logo printed on: Conference brochure Black & white page of official program book• Acknowledgement on conference advertising• Organization information inserted in conference tote bags• 6’ x 8’ display/exhibit area• Registration and badges for up to 3 people
Prostate Cancer Research Institute Sponsoring & Exhibiting Opportunities - 2
Sponsoring & Exhibiting Opportunities1. Please indicate your level of involvement
Underwriting Sponsor ($50,000)Platinum Sponsor ($30,000)GoldSponsor($20,000)Silver Sponsor ($10,000)Exhibitor ($5,000)Other ($__________)
2. Dash for Dads — South Bay:If you would like to support the June 17 “Dash for Dads” race in Manhattan Beach, please indicate your level of involvement.
$5,000$1,000 $500Other($__________)
Prostate Cancer Research Institute APPLICATION - 1
3. Contact InformationPlease provide information for the contact person from your organization who will receive all correspondence for this event. Please provide an e-mail address if you wish to receive additional information and updates about the event.
Organization Name
Primary ContactStreet Address
City, State, Zip
PhoneE-mail
4. Official Program Book
Check here if you wish to use the information in #3 above for official program book.
Check here if you are attaching a separate document or instruction on design/name to use.
$2,500
Sponsoring & Exhibiting Opportunities
Prostate Cancer Research Institute APPLICATION - 2
5. Description of Products and ServicesAll applications must be accompanied by a complete description of product/service information and literature to be dis-played. If you need more space, please attach a separate sheet with the required information.
6. Exhibiting/DisplayingPCRI encourages exchanges and interaction among members of the prostate cancer community. The exhibit hall is designed to make this exchange possible.
Check here if you are interested in setting up an exhibit and wish to reserve an exhibit space.
In the space below, please list any special requirements you may have:
Exhibit space availability and assignments are based on the fol-lowing:
a. Level of participation (see #1 above)b. Amount of space requiredc. Date application is received
Sponsoring & Exhibiting Opportunities7. Payment TermsPlease see Application page 4 for full Conference Terms & Conditions.
The Prostate Cancer Research Institute (PCRI) is a 501 (c)(3) not-for-profit charitable organization. Its Fed-eral Tax ID # is 95-4617875.
Payments relating to the 2012 Conference are consid-ered direct support to PCRI’s programs, and are tax-deductible (please consult your tax professional).
Upon receipt of your payment and upon request, PCRI will issue a donation acknowledgment letter.
Please make your check payable to “Prostate Cancer Research Institute.” Exhibitors not making timely pay-ments may forfeit their reserved space.
8. AgreementWe, the exhibiting organization, have received, read and accepted the conditions for exhibiting, as outlined in the Conference Terms and Conditions (Application page 4). We and our representatives agree to abide by the exhibitor rules and regulations, all of the terms of which are made a part hereof by this reference and fully incorporated herein.
Signature_______________________________________Date___________________________________________Printed Name____________________________________Title____________________________________________
PLEASE DO NOT WRITE BELOW THE LINE.
Please return completed application to:
Prostate Cancer Research Institute (PCRI)Sponsorships & Exhibits
5777 W. Century Blvd., Suite 800Los Angeles, CA 90045
Organization Name
Primary Contact
Street Address
City, State, Zip
Phone
Prostate Cancer Research Institute APPLICATION - 3
Terms & Conditions2011 Prostate Cancer ConferenceTerms and Conditions
I. Scope. These terms and conditions shall be binding upon Prostate Cancer Research Institute (PCRI), Ex-hibitor and their respective Agents and representatives, including but not limited to Exhibitor, contracted labor such as Customer Appointed Contractors and Installation and Dismantle Companies, and any other party with aninterestintheGoods.Eachshallhavethebenefitofandbeboundbyallprovisionsstatedherein,includingbut not limited to time limits and limitations of liability.
II. Exhibitor to PCRI. Mutual Obligation Indemnification. Exhibitor shall defend, hold harmless and indemnify PCRI from and against any claims, lawsuits, demands, liability, costs and expenses, including rea-sonable attorney’s fees and court costs, resulting from any injury to or death of persons, or damage to property otherthanGoods,relatingtoorarisingfromperformanceofservicesherein.Customeragreestoindemnifyandhold PCRI harmless for any and all acts of its representatives and agents, including but not limited to Exhibitor Appointed Contractors and Installation and Dismantle Companies, any subtenant or other user of its space or any agents or employees engaged in business on behalf of Exhibitor or present at Exhibitor’s invitation, including supervision of labor. Exhibitor’s obligations under this provision shall not apply to PCRI’s own negligence and/or willfulmisconduct.EXHIBITORACKNOWLEDGESTHATTHESHOWSITEISANACTIVEWORKZONEANDCUSTOMER,ITSAGENTS,EMPLOYEESANDREPRESENATIVESAREPRESENTATTHEIROWNRISK.
III. PCRI to Exhibitor. TotheextentofPCRI’sownnegligenceand/orwillfulmisconduct,andsubjecttothelimitations of liability below, PCRI shall defend, hold harmless and indemnify Exhibitor from and against any claims, lawsuits, demands, liability, costs and expenses including reasonable attorney’s fees and court costs result-ingfromanyinjurytoordeathofpersonordamagetopropertyotherthanGoods.PCRI’sobligationsunderthisprovision shall not apply to claims for bodily injury arising a) from Exhibitor’s presence in areas which have been marked as “off limits to Exhibitors”, and b) when Exhibitors are present in the facility prior or subsequent to the effective dates or hours of Exhibitor’s space lease with show management.
IV. Disclaimer and Limitation of Liability. UNDERNOCIRCUMSTANCESWILLANYPARTYBELIA-BLEFORSPECIAL,INCIDIENTAL,CONSEQUENTIAL,INDIRECTORPUNITIVEDAMANGES,INCLUD-INGBUTNOTLIMITEDTOLOSSOFPROFITSORINCOME.PCRISHALLBELIABLE,SUBJECTTOTHELIMITIATIONCONTAINEDHEREIN,FORLOSSORDAMAGETOGOODSONLYIFSUCHLOSSORDAMAGEISCAUSEDBYTHEDIRECTNEGLGIENCEORWILLFULMISCONDUCTOFPCRI.CLAIMSPRESENTEDFORLOSSORDAMAGEARISINGOUTOFANYOTHERINCIDENTSWILLBEDENIED.
V. Insurance. PCRI does not offer of provide insurance. It is the obligation of Exhibitor to ensure goods are insured at all times. Loss or theft of the goods in storage or in transit to and from the show and or while on the show floor is the sole responsibility of Exhibitor. Exhibitor should arrange for all Risk Coverage.
VI. Liability Insurance. Exhibitor shall provide PCRI with a certificate of liability insurance naming “2011Prostate Cancer Conference” as an additional named insured.
Prostate Cancer Research Institute APPLICATION - 4 Agen
da &
Lear
ning O
bjecti
ves
Agen
da &
Lear
ning O
bjecti
ves
FAC
ULT
YTO
PIC
Nat
han
Rou
ndy,
PC
RI E
duca
tiona
l Fac
ilita
tor
Pros
tate
Can
cer 1
01Ja
n M
anar
ite, P
CRI
Sen
ior E
duca
tiona
l Fac
ilita
tor
Pros
tate
Can
cer 2
01
FAC
ULT
YTO
PIC
LEA
RN
ING
OBJ
ECTI
VES
Dav
id H
eber
, MD
D
irect
or, U
CLA
Cen
ter f
or H
uman
Nut
ritio
nLi
fest
yle
Cha
nges
, Sup
plem
ents
, Pre
scrip
tions
and
ev
en S
urge
ry to
Pro
mot
e th
e “P
erfe
ct” B
ody.
•D
iets
that
affe
ct c
ance
r gro
wth
•Ex
erci
se th
at b
uild
s lea
n bo
dy m
ass
•Su
pple
men
ts th
at m
ay b
e de
lete
rious
for
canc
er p
atie
nts
•H
ow c
an su
rger
y m
ake
a di
ffere
nce?
•Pr
escr
iptio
n m
edic
atio
ns th
at p
rom
ote
a m
ore
lean
bod
yJo
hn B
lask
o, M
DRa
diat
ion
Onc
olog
ist, S
eattl
e Pr
osta
te In
stitu
teW
hatt
heH
eckDoYo
uDowith
aT
inyCan
cer?
Ther
agen
ics,
seed
impl
ants
•D
efine
par
amet
ers o
f app
ropr
iate
can
dida
tes
for a
ctiv
e su
rvei
llanc
e•
Imag
ing
and
biop
sy m
etho
ds fo
r sta
ging
and
m
onito
ring
pros
tate
can
cer
Ric
hard
Lam
, MD
Rese
arch
Dire
ctor
, Pro
stat
e O
ncol
ogy
Spec
ialis
tsTr
eatin
gHigh-
Risk
Pro
stateCan
cer
Prov
enge
,Zyt
iga,M
DV-
3100
,Den
osum
ab,A
lpha
radi
n•
Prot
ocol
s for
com
bini
ng ra
diat
ion,
bra
chy-
ther
apy
and
andr
ogen
dep
rivat
ion
•Re
view
the
late
st ta
rget
ing
tech
nolo
gy fo
r IM
RT,inc
ludi
ngC
alyp
so•
Pres
ent s
tatu
s of a
djuv
ant c
hem
othe
rapy
•Se
lectin
gm
enfo
rIM
RTto
pelvicl
ymph
no
des
Cha
rles
“Snu
ffy”
Mye
rs, M
DM
edic
al O
ncol
ogist
, Am
eric
an In
stitu
te fo
r Dise
ases
of t
he P
rost
ate
How
to M
anag
e Pr
osta
te C
ance
r if i
t Com
es B
ack
after
Su
rger
y or
Rad
iatio
n•
Role
of d
utes
terid
e w
ith in
term
itten
t hor
-m
one
bloc
kade
•Si
gnifi
canc
e of
PSA
dou
blin
g tim
e•
Des
igni
ng ta
rget
ed th
erap
y fo
r olig
omet
as-
tase
s•
Prot
ectiv
e eff
ect o
f Xge
va o
n ca
lciu
m lo
ss
and
canc
er p
rogr
essio
n
FRID
AY, S
EPTE
MB
ER 7
SATU
RD
AY, S
EPTE
MB
ER 8
Agen
da &
Lear
ning O
bjecti
ves
Rob
ert D
reic
er, M
D
Cha
irman
,Dep
artm
ento
fSolid
Tum
orO
ncolog
y,Cleve
land
Clin
ic
Trea
tingPr
ostateC
ance
rtha
thas
Metas
tasiz
ed•
Use
ofn
ewage
ntss
uch
asP
rove
nge,
Jevt
ana,
Cab
azita
xel,
Abi
rate
rone
•C
hem
o co
mbi
natio
ns a
nd sc
hedu
les
•Su
ppor
tive
ther
apy
with
Ava
stin
, Neu
last
a an
d A
rane
sp•
Bone
supp
ortw
ithX
geva
,Zom
eta&
Prov
enge
Euge
ne K
won
, MD
Prof
esso
r of U
rolo
gy, Th
e M
ayo
Clin
icTh
eCom
ingW
aveof
New
Tre
atm
ent
TAK-7
00,C
urster
sin,A
lpha
radi
n•
Futu
rero
leofM
DV-
3100
,Ipi
limum
ab,D
a-sa
tinib
and
XL-
184
•New
imag
ingbr
eakt
hrou
ghs,
such
asP
ET
scan
ning
, how
it w
ill a
ffect
sele
ctio
n of
th
erap
yJo
hn M
ulha
ll, M
DD
irect
or, M
ale
Sexu
al a
nd R
epro
duct
ive
Med
icin
e Pr
ogra
m,
Mem
orialS
loan
-Ketterin
gCan
cerC
enter
Prev
entin
gTr
eatm
ent-Re
latedSide
Effe
cts
•Kno
wco
mm
ondefi
nitio
nsand
cau
seso
fse
xual
dys
func
tion
•Le
arn
met
hods
to p
reve
nt o
r min
imiz
e th
e im
pact
of t
reat
men
t on
sexu
al d
ysfu
nctio
n•
Revi
ew m
oder
n m
edic
al &
surg
ical
trea
t-m
ents
for s
exua
l dys
func
tion
•D
iscus
s met
hods
to im
prov
e pa
tient
/doc
tor
com
mun
icat
ion
on se
xual
topi
csLo
ri B
uckl
ey, P
syD
Th
erap
ist, D
r. Lo
ri Bu
ckle
y &
Ass
ocia
tes
Issu
es o
f Int
imac
y•
Disc
uss m
etho
ds fo
r ove
rcom
ing
barr
iers
to
intim
acy,
such
as l
ow li
bido
and
ED
SATU
RD
AY, S
EPTE
MB
ER 8
(CO
NTI
NU
ED)
SUN
DAY
, SEP
TEM
BER
9
Mar
k M
oyad
, MD
Seni
or R
esea
rch
Ass
ocia
te, U
nive
rsity
of M
ichi
gan
Med
ical
Sch
ool
Mar
k Sc
holz
, MD
Med
ical
Dire
ctor
, Pro
stat
e O
ncol
ogy
Spec
ialis
ts
Satu
rday
review
,Q&A
8 A
M t
o 9
AM
•Que
stio
nson
prev
entio
n,tr
eatm
ent,
side
effec
ts a
nd su
pple
men
ts
Mar
k M
oyad
, MD
Seni
or R
esea
rch
Ass
ocia
te, U
nive
rsity
of M
ichi
gan
Med
ical
Sch
ool
Mar
k Sc
holz
, MD
Med
ical
Dire
ctor
, Pro
stat
e O
ncol
ogy
Spec
ialis
ts
Satu
rday
review
,Q&A
8 A
M t
o 9
AM
•Que
stio
nson
prev
entio
n,tr
eatm
ent,
side
effec
ts a
nd su
pple
men
ts
Agen
da &
Lear
ning O
bjecti
ves
ASK
TH
E EX
PERT
SM
icha
el S
tein
berg
, MD
Cha
ir of
Rad
iatio
n O
ncol
ogy,
UC
LA
Radi
atio
n•
Disc
uss v
ario
us ty
pes o
f rad
iatio
n in
clud
ing
IMRT
,Pro
ton
andBr
achy
ther
apy
•Re
view
pot
entia
l acu
te a
nd ch
roni
c sid
e ef
-fe
cts o
f rad
iatio
nSt
ephe
n St
rum
, MD
Med
ical
Onc
olog
istH
orm
one
Bloc
kade
Ric
hard
Lam
, MD
Che
mot
hera
py,L
upro
n,M
DV-
3100
,Zyt
iga,Firm
agon
•Le
arn
abou
t Xge
va th
erap
y fo
r tre
atm
ent o
f m
etas
tatic
dise
ase
•C
over
com
mon
type
s of c
hem
othe
rapy
, in
clud
ingTa
xotere
,Cab
azita
xel
Duk
e Ba
hn, M
DM
edic
al D
irect
or, P
rost
ate
Inst
itute
of A
mer
ica
Act
ive
Surv
eilla
nce
&Fo
cal Th
erap
y•
Disc
uss i
mag
ing
met
hods
for m
onito
ring
pros
tate
can
cer
•Re
view
adv
anta
ges a
nd d
isadv
anta
ges o
f fo
cal t
hera
py co
mpa
red
to tr
aditi
onal
trea
t-m
ent
•Kno
wth
edi
fficu
lties
assoc
iatedwith
acc
u-ra
te tu
mor
loca
lizat
ion
Dav
id H
eber
, MD
Nut
ritio
n an
d Fi
tnes
s•
Revi
ew th
e ro
le o
f die
t in
canc
er m
anag
e-m
ent
•U
nder
stan
d th
e im
pact
of d
iet o
n ca
ncer
gr
owth
•Id
entif
y w
hich
food
type
s are
del
eter
ious
an
d w
hich
can
inhi
bit c
ance
r gro
wth
Cha
rles
“Snu
ffy”
Mye
rs, M
DHor
mon
eTh
erap
y,Zy
tiga
•D
iscus
s and
roge
n bl
ocka
de in
its m
any
form
s, in
clud
ing
LHRH
ago
nist
s•
Und
erstan
dth
eev
olving
rolefo
rZyt
iga,
MDV-
3100
and
oth
erse
cond
aryho
rmon
al
inte
rven
tions
•Re
view
met
hods
for m
inim
izin
g th
e sid
e eff
ects
of a
ndro
gen
bloc
kade
Euge
ne K
won
, MD
Surg
ery
•Be
fam
iliar
with
all
the
new
est a
nd m
ost
com
mon
surg
ery
optio
ns•
Disc
uss p
oten
tial s
ide
effec
ts o
f tre
atm
ent,
incl
udin
g se
xual
dys
func
tion
SUN
DAY
, SEP
TEM
BER
9 (C
ON
TIN
UED
)